AirXpanders 100 per cent success with trial

Company News

by Jessica Amir

AirXpanders (ASX:AXP) has achieved 100 per cent successful expansion and exchange of breast impants in 50 women who had mastectomies.

It comes as the medical device company’s fifth prospective trial also confirmed doctor and patient satisfaction, ease of use and convenience with its AeroForm Tissue Expander System.

The company presented these findings at the 86th Plastic Surgery annual scientific meeting in Orlando.

AeroForm offers a needle free alternative for women who choose to have reconstructive surgery after a mastectomy.

Shares in AirXpanders (ASX:AXP) are trading 0.68 per cent higher to 74 cents.


Jessica Amir

Finance News Network
Jessica joined FNN in January 2017 after having worked in financial advising for seven years and in TV journalism for seven years, specialising in finance, equities and analysis. She has interviewed former Prime Ministers of Australia, Tony Abbott, Julia Gillard and Kevin Rudd and ex Treasurer Jo Hockey. Jessica has worked as a journalist with Sky News Business, ABC 1, ABC's The Business, ABC24 and has also been a regional Channel 7 and 9 TV reporter with Prime7 and Win News.